Discordance between anti-β2-glycoprotein-I and anti-cardiolipin antibodies in patients with clinical criteria of antiphospholipid syndrome

Clinical and Experimental Rheumatology

Volumn 23, Issue 4, 2005, Pages 525-528

  Micheloud, Dariela ^a   Sánchez Ramón, Silvia ^a   Carbone, Javier ^a   Rodríguez Molina, Juan J ^a   Fernández Cruz, Eduardo ^a   López Longo, Francisco J ^a   Rodríguez Mahou, Margarita ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

Anti beta2 glycoprotein I antibodies; Anticardiolipin antibodies; Antiphospholipid syndrome; Enzyme linked immunosorbent assay; Thrombosis

Indexed keywords

BETA2 GLYCOPROTEIN 1 ANTIBODY; CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LUPUS ANTICOAGULANT; BETA2 GLYCOPROTEIN 1; GLYCOPROTEIN;

ADULT; AGE DISTRIBUTION; AGED; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; AUTOIMMUNE DISEASE; BLOOD SAMPLING; CLINICAL EXAMINATION; CLINICAL FEATURE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SERODIAGNOSIS; SEX DIFFERENCE; SPAIN; THROMBOSIS; BLOOD; IMMUNOLOGY; MIDDLE AGED; PREGNANCY; PRESCHOOL CHILD; REPRODUCIBILITY; RISK; RISK FACTOR;

AGED; ANTIBODIES, ANTICARDIOLIPIN; ANTIPHOSPHOLIPID SYNDROME; BETA 2-GLYCOPROTEIN I; CHILD, PRESCHOOL; FEMALE; GLYCOPROTEINS; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; PREGNANCY; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; RISK FACTORS; SPAIN;

EID: 26844431994     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. LEVINE JS, BRANCH DW, RAUCH J: The antiphospholipid syndrome. N Eng J Med 2002; 346: 752-6.
2. ARVIEUX J, ROUSSEL B, JACOB MC, COLOMB MG: Measurement of anti-phospholipid antibodies by ELISA using beta 2-glycoprotein I as an antigen. J Immunol Methods 1991; 143: 223-9.
3. MATSUURA E, IGARASHI Y, YASUDA T, TRIPLETT DA, KOIKE T: Anticardiolipin antibodies recognize beta 2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface. J Exp Med 1994; 179: 457-62.
4. MATSUURA E, IGARASHI Y, YASUDA T, TRIPLETT DA, KOIKE T: Anti-beta(2)-glycoprotein I antibodies and the antiphospholipid syndrome. Autoimmun Rev 2003; 2: 229-34.
5. SANFILIPO SS, KHAMASHTA MA, ATSUMI T et al.: Antibodies to beta 2-glycoprotein I: a potential markers for clinical features of antiphospholipid antibody syndrome in patients with systematic lupus erythematosus. J Rheumatol 1998; 25: 2131-4.
6. 2-glycoprotein I antibodies in pediatric systemic lupus erythematosus and antiphospholipid syndrome. Arthritis Rheum 2002; 47: 4414-20.
7. INANÇ M, DONOHOE S, RAVIRAJAN CT et al.: Anti-2-glycoprotein 1, anti-prothrombin and anticardiolipin antibodies in a longitudinal study of patients with systemic lupus erythematosus and the antiphospholipid syndrome. J Rheumatol 1998; 37: 1089-94.
8. MCNALLY T, MACKIE IJ, MACHIN SJ, ISENBERG DA: Increased levels of beta 2 glycoprotein-I antigen and beta 2 glycoprotein-I binding antibodies are assocaited with a history of thromboembolic complications in patients with SLE and primary antiphospholipid syndrome. Br J Rheumatol 1995; 34: 1031-6.
9. BRUCE IN, CLARK-SOLONINKA CA, SPITZER KA, GLADMAN DD, UROWITZ MB, LASKIN CA: Prevalence of antibodies to beta2-glycoprotein I in systemic lupus erythematosus and their association with antiphospholipid antibody syndrome criteria: a single center study and literature review. J Rheumatol 2000; 27: 2833-7.
10. CABIEDES J, CABRAL AR, ALARCON-SEGOVIA D: Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-beta 2-glycoprotein-I than with antiphospholipid antibodies. J Rheumatol 1995; 22: 1899-906.
11. CABRAL AR, AMIGO MC, CABIEDES J, ALARCÓN-SEGOVIA D: The antiphospholipid/cofactor syndromes: a primary variant with antibodies to beta 2-glycoprotein I but not antibodies detectable in standard antiphospholipid assays. Am J Med 1996; 101: 472-81.
12. ALARCON-SEGOVIA D, MESTANZA M, CABIEDES J, CABRAL AR: The antiphospholipid/cofactor syndromes II. A variant in patients with systemic lupus erythematosus with antibodies to beta 2-glycoprotein I but no antibodies detectable in standard antiphospholipid assays. J Rheumatol 1997; 24: 1545-51.
13. WILSON WA, GHARAVI AE, KOIKE T et al.: International consensus statements on preliminary classification criteria for definite antiphospholipid syndrome: report of international workshop. Arthitis Rheum 1999; 42: 1309-11.
14. TAN EM, COHEN AS, FRIES JF et al.: The 1982 revised criteria for the classification of systematic lupus. Arthritis Rheum 1982; 25: 1271-7.
15. ARNETT FC, EDWORTHY SM, BLOCH DA et al.: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 3: 315-24.
16. HUNDER GC, AREND WP, BLOCH DA, CALABRESE LH, FAUCI AS: The American College of Rheumatology 1990 criteria for the classification of the vasculities. Arthritis Rheum 1990; 33: 1065-144.
17. BLANCO AN, GRAND BE, PIERONI G, PEÑALVA LB, VOTO LS, LAZZARI MA: Behavior of diluted activated partial thromboplastin time in pregnant women with a lupus anticoagulant. Am J Clin Pathol 1993; 100: 99-102.
18. 2-glycoprotein I antibody affinity. J Immunol, 1998, 161: 2038-43.
19. ROSNER E, PAUZNER R, LUSKY A, MODAN M, MANY A: Detection and quantitative evaluation of lupus circulating anticoagulant activity. Thromb Haemost 1987; 57: 144-147.
20. AMENGUAL O, ATSUMI T, KHAMASHTA MA, KOIKE T, HUGHES GRV: Specificity of ELISA for antibody to B2 glycoprotein in patients with antiphospholipid syndrome. Br J Rheumatol 1996; 5: 388-92.
21. LOPEZ LR, DIER KJ, LOPEZ D, MERRILL JT, FINK CA: Anti-beta 2-glycoprotein I and antiphosphatidylserine antibodies are predictors of arterial thrombosis in patients with antiphospholipid syndrome. Am J Clin Pathol 2004; 121: 142-9.
22. SHOENFELD Y, KRAUSE I, KVAPIL F et al.: Prevalence and clinical correlations of antibodies against six beta2-glycoprotein-I-related peptides in the antiphospholipid syndrome. J Clin Immunol 2003; 23: 377-83.